anonymous
Guest
anonymous
Guest
Does anyone know what the deal is with the proposed addition of reps to the oncology sales force?
they are switching everybody's targets for STS.Does anyone know what the deal is with the proposed addition of reps to the oncology sales force?
they are switching everybody's targets for STS.
Does anyone know what the deal is with the proposed addition of reps to the oncology sales force?
Pray for Japan.
Eisai is in oncology?
Phuk japan!Pray for Japan.
What is STS?they are switching everybody's targets for STS.
What is STS?
Ok mr primary care. STS is soft tissue sarcoma
Oh joy. Mirrored reps. That always works out perfectly. What once office with limited access already wouldn't want to see 2 Eisai reps instead of just one.they are adding mirrored reps in about 20-30 territory's that are considered volume potential. One rep will be 89% haloven the other rep 80% lemvina
Oh joy. Mirrored reps. That always works out perfectly. What once office with limited access already wouldn't want to see 2 Eisai reps instead of just one.
The clowns running Eisai oncology don't have one original thought between them..